Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | |
|---|---|---|---|---|---|
| Revenue | $3.6B | $2.7B | $2.8B | $4.1B | $3.1B |
| YoY growth | +16.5% | +17.9% | +12.0% | +9.7% | +12.7% |
| Gross margin | — | — | — | — | — |
| Operating margin | 21.0% | 3.2% | 9.7% | 39.7% | 19.8% |
| Net income | $816M | $160M | $341M | $1.4B | $642M |
| Diluted EPS | — | — | — | — | — |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
Similar than in the previous 10-Q (2026-05-07: +17, +2 points)
10-Q of 2026-08-06 · 31.7% positive sentences, 9.5% negative · 199 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Akre Capital · Chuck Akre
held since Q2 2024 |
3.3% | $169.4M | -42% |
| Markel Group · Tom Gayner
held since Q3 2024 |
0.3% | $34.7M | = |
| Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier |
0.1% | $33.9M | +776% |
| ARK Investment Management · Cathie Wood
held since Q1 2025 |
0.1% | $21.2M | -8% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for ABNB →
| 2026-10-12 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $703K | SEC ↗ |
| 2026-10-12 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $541K | SEC ↗ |
| 2026-10-12 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $466K | SEC ↗ |
| 2026-10-12 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $372K | SEC ↗ |
| 2026-10-12 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $167K | SEC ↗ |
| 2026-09-28 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $958K | SEC ↗ |
| 2026-09-28 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $890K | SEC ↗ |
| 2026-09-28 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $192K | SEC ↗ |
| 2026-09-28 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $74K | SEC ↗ |
| 2026-09-28 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $21K | SEC ↗ |
| 2026-09-15 | Bernstein David C · Officer | Sell (10b5-1 plan) | $252K | SEC ↗ |
| 2026-09-14 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $1.8M | SEC ↗ |
| 2026-09-14 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $241K | SEC ↗ |
| 2026-09-14 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $217K | SEC ↗ |
| 2026-09-14 | Blecharczyk Nathan · Officer | Sell (10b5-1 plan) | $102K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.